Evaluation of circulating determinants of beta-cell function in women with and without gestational diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 7, 2016, Pages 2683-2691

  Retnakaran, Ravi ^a,b,c   Ye, Chang ^a   Kramer, Caroline K ^a,b   Connelly, Philip W ^b,d   Hanley, Anthony J ^a,b   Sermer, Mathew ^a   Zinman, Bernard ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 CARBOXY 4 METHYL 5 PROPYL 2 FURANPROPANOIC ACID; DRUG METABOLITE; FATTY ACID; GLUCOSE; HUMAN PLACENTA LACTOGEN; INSULIN; PROLACTIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERGLYCEMIA; INSULIN SECRETION SENSITIVITY INDEX 2; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PREDICTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; BLOOD; CASE CONTROL STUDY; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY;

ADULT; BIOMARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; PREGNANCY;

EID: 84974584987     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1402     Document Type: Article

References (38)

1. st century approaches. Diabetes. 2015; 64:327-334.
2. Retnakaran R. Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women. Curr Diabetes Rev. 2009;5:239-244.
3. Ernst S, Demirci C, Valle S, Velazquez-Garcia S, Garcia-Ocaña A. Mechanisms in the adaptation of maternal beta-cells in pregnancy. Diabetes Manag. 2011;1:239-248.
4. Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011;18:409-416.
5. Butler AE, Cao-Minh L, Galasso R, et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia. 2010;53:2167-2176.
6. Genevay M, Pontes H, Meda P. Beta-cell adaptation in pregnancy: a major difference between humans and rodents. Diabetologia. 2010;51:2089-2092.
7. Nalla A, Ringholm L, Søstrup B, et al. Implications for the offspring of circulating factors involved in beta cell adaptation in pregnancy. Acta Obstet Gynecol Scand. 2014;93:1181-1189.
8. Drynda R, Peters CJ, Jones PM, Bowe JE. The role of non-placental signals in the adaptation of islets to pregnancy. Horm Metab Res. 2015;47:64-71.
9. Xu Y, Wang X, Gao L, et al. Prolactin-stimulated survivin induction is required for beta cell mass expansion during pregnancy in mice. Diabetologia. 2015;58:2064-2073.
10. Ramos-Román MA. Prolactin and lactation as modifiers of diabetes risk in gestational diabetes. Horm Metab Res. 2011;43: 593-600.
11. Huang C, Snider F, Cross JC. Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology. 2009;150:1616-1626.
12. Prentice KJ, Luu L, Allister EM, et al. The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction. Cell Metab. 2014;19:653-666.
13. Nolan CJ. Lipotoxicity, beta-cell dysfunction, and gestational diabetes. Cell Metab. 2014;19:553-554.
14. Kühl C, Gaede P, Klebe JG, Pedersen J. Human placental lactogen concentration during physiological fluctuations of serum glucose in normal pregnant and gestational diabetic women. Acta Endocrinol. 1975;80:365-373.
15. Skouby SO, Kühl C, Hornnes PJ, Andersen AN. Prolactin and glucose tolerance in normal and gestational diabetic pregnancy.Obstet Gynecol. 1986;67:17-20.
16. Montelongo A, Lasunción MA, Pallardo LF, Herrera E. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes. 1992;41:1651-1659.
17. Luthman M, Stock S, Werner S, Bremme K. Growth hormone-binding protein in plasma is inversely correlated to placental lactogen and augmented with increasing body mass indexinhealthy pregnant women and women with gestational diabetes mellitus. Gynecol Ob-stet Invest. 1994;38:145-150.
18. Grigorakis SI, Alevizaki M, Beis C, Anastasiou E, Alevizaki CC, Souvatzoglou A. Hormonal parameters in gestational diabetes mel-litus during the third trimester: high glucagon levels.Gynecol Obstet Invest. 2000;49:106-109.
19. Couch SC, Philipson EH, Bendel RB, Pujda LM, Milvae RA, Lammi-Keefe CJ. Elevated lipoprotein lipids and gestational hormones in women with diet-treated gestational diabetes mellitus compared to healthy pregnant controls. J Diabetes Complications. 1998;12:1-9.
20. Henderson CE, Divon MY. Combining human placental lactogen with routine glucose challenge tests. Prim Care Update Ob Gyns. 1998;5:189-190.
21. Retnakaran R, Kramer CK, Ye C, et al. Fetal sex and maternal risk of gestational diabetes mellitus: the impactofhavinga boy.Diabetes Care. 2015;38:844-851.
22. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-1057.
23. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-1470.
24. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care. 2001;24:1602-1607.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
26. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity. 2008;16:1901-1907.
27. Retnakaran R, Qi Y, Goran M, Hamilton J. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabetes Med. 2009;26:1198-1203.
28. Kim H, Toyofuku Y, Lynn FC, et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med. 2010;16:804-808.
29. Zhang H, Zhang J, Pope CF, et al. Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen. Diabetes. 2010;59:143-152.
30. Karnik SK, Chen H, McLean GW, et al. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science. 2007;318:806-809.
31. Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia. 2009;52:1003-1012.
32. Le TN, Elsea SH, Romero R, Chaiworapongsa T, Francis GL. Pro-lactin receptor gene polymorphisms are associated with gestational diabetes. Genet Test Mol Biomarkers. 2013;17:567-571.
33. Lankinen MA, Hanhineva K, Kolehmainen M, et al. CMPF does not associate with impaired glucose metabolism in individuals with features of metabolic syndrome. PLoS One. 2015;10:e0124379.
34. Zhang C, Bao W, Rong Y, et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update. 2013;19:376-390.
35. Miyamoto Y, Iwao Y, Mera K, et al. A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage to proximal tubular cells via the generation of a radical intermediate. Biochem Pharmacol. 2012;84:1207-1214.
36. Hannemann K, Puchta V, Simon E, Ziegler H, Ziegler G, Spiteller G. The common occurrence of furan fatty acids in plants. Lipids. 1989; 24:296-298.
37. Berdeaux O, Fontagné S, Sémon E, Velasco J, Sébédio JL, Dobar-ganes C. A detailed identification study on high-temperature degradation products of oleic and linoleic acid methyl esters by GC-MS and GC-FTIR. Chem Phys Lipids. 2012;165:338-347.
38. Jacovetti C, Abderrahmani A, Parnaud G, et al. MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.J Clin Invest. 2012;122:3541-3551.